Systemic Therapy for Metastatic Pancreatic Cancer

por Ettrich, Thomas J., Seufferlein, Thomas
Publicado 2021

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy

por Sturm, Niklas, Ettrich, Thomas J., Perkhofer, Lukas
Publicado 2022

Gastroenteropancreatic Neuroendocrine Tumors—Current Status and Advances in Diagnostic Imaging

por Vogele, Daniel, Schmidt, Stefan A., Gnutzmann, Daniel, Thaiss, Wolfgang M., Ettrich, Thomas J., Kornmann, Marko, Beer, Meinrad, Juchems, Markus S.
Publicado 2023

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA

por Berger, Andreas W., Schwerdel, Daniel, Welz, Hanna, Marienfeld, Ralf, Schmidt, Stefan A., Kleger, Alexander, Ettrich, Thomas J., Seufferlein, Thomas
Publicado 2017

Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer

por Berger, Andreas W., Schwerdel, Daniel, Ettrich, Thomas J., Hann, Alexander, Schmidt, Stefan A., Kleger, Alexander, Marienfeld, Ralf, Seufferlein, Thomas
Publicado 2017

Advantages of a multi-state approach in surgical research: how intermediate events and risk factor profile affect the prognosis of a patient with locally advanced rectal cancer

por Manzini, G., Ettrich, T. J., Kremer, M., Kornmann, M., Henne-Bruns, D., Eikema, D. A., Schlattmann, P., de Wreede, L. C.
Publicado 2018

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative,...

por Perkhofer, L., Berger, A. W., Beutel, A. K., Gallmeier, E., Angermeier, S., Fischer von Weikersthal, L., Goetze, T. O., Muche, R., Seufferlein, T., Ettrich, T. J.
Publicado 2019

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated

por d’Almeida, Sascha, Markovic, Sinisa, Hermann, Patrick, Bracht, Hendrik, Peifer, Johannes, Ettrich, Thomas J., Imhof, Armin, Zhou, Shaoxia, Weiss, Manfred, Viardot, Andreas, Rottbauer, Wolfgang, Dahme, Tillman
Publicado 2023

Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

por Weiss, L., Karthaus, M., Riera-Knorrenschild, J., Kretzschmar, A., Welslau, M., Vehling-Kaiser, U., Pelz, H., Ettrich, T.J., Hess, J., Reisländer, T., Klein, A., Heinemann, V.
Publicado 2022

Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information

por Ettrich, T. J., Schwerdel, D., Dolnik, A., Beuter, F., Blätte, T. J., Schmidt, S. A., Stanescu-Siegmund, N., Steinacker, J., Marienfeld, R., Kleger, A., Bullinger, L., Seufferlein, T., Berger, A. W.
Publicado 2019

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter...

por Krug, Sebastian, Kegel, Thomas, Gress, Thomas M., Rinke, Anja, Apostolidis, Leonidas, Jann, Henning, König, Alexander, Hörsch, Dieter, Schrader, Jörg, Ettrich, Thomas J., Richter, Michael, Steighardt, Jörg, Michl, Patrick
Publicado 2021

Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients

por Waldenmaier, Mareike, Schulte, Lucas, Schönfelder, Jonathan, Fürstberger, Axel, Kraus, Johann M., Daiss, Nora, Seibold, Tanja, Morawe, Mareen, Ettrich, Thomas J., Kestler, Hans A., Kahlert, Christoph, Seufferlein, Thomas, Eiseler, Tim
Publicado 2022

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

por Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Publicado 2016

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled...

por Ettrich, Thomas J., Berger, Andreas W., Perkhofer, Lukas, Daum, Severin, König, Alexander, Dickhut, Andreas, Wittel, Uwe, Wille, Kai, Geissler, Michael, Algül, Hana, Gallmeier, Eike, Atzpodien, Jens, Kornmann, Marko, Muche, Rainer, Prasnikar, Nicole, Tannapfel, Andrea, Reinacher-Schick, Anke, Uhl, Waldemar, Seufferlein, Thomas
Publicado 2018

Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score

por Gaiser, Maria R., Lorenzen, Sylvie, Merx, Kirsten, Trojan, Jörg, Ocvirk, Janja, Ettrich, Thomas J., Al‐Batran, Salah‐Eddin, Schulz, Holger, Homann, Nils, Feustel, Hans‐Peter, Schatz, Michael, Kripp, Melanie, Schulte, Nadine, Heeger, Steffen, Vlassak, Soetkin, Koch, Winfried, Hofheinz, Ralf‐Dieter
Publicado 2019

A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response

por Beutel, Alica K., Schütte, Lena, Scheible, Jeanette, Roger, Elodie, Müller, Martin, Perkhofer, Lukas, Kestler, Annika M. T. U., Kraus, Johann M., Kestler, Hans A., Barth, Thomas F. E., Lemke, Johannes, Kornmann, Marko, Ettrich, Thomas J., Gout, Johann, Seufferlein, Thomas, Kleger, Alexander
Publicado 2021

Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus p...

por Sommerhäuser, G., Kurreck, A., Stintzing, S., Heinemann, V., von Weikersthal, L. Fischer, Dechow, T., Kaiser, F., Karthaus, M., Schwaner, I., Fuchs, M., König, A., Roderburg, C., Hoyer, I., Quante, M., Kiani, A., Fruehauf, S., Müller, L., Reinacher-Schick, A., Ettrich, T. J., Stahler, A., Modest, D. P.
Publicado 2022

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II tr...

por Hartlapp, I., Valta-Seufzer, D., Siveke, J.T., Algül, H., Goekkurt, E., Siegler, G., Martens, U.M., Waldschmidt, D., Pelzer, U., Fuchs, M., Kullmann, F., Boeck, S., Ettrich, T.J., Held, S., Keller, R., Anger, F., Germer, C.T., Stang, A., Kimmel, B., Heinemann, V., Kunzmann, V.
Publicado 2022

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer

por Berger, Andreas W., Schwerdel, Daniel, Reinacher-Schick, Anke, Uhl, Waldemar, Algül, Hana, Friess, Helmut, Janssen, Klaus-Peter, König, Alexander, Ghadimi, Michael, Gallmeier, Eike, Bartsch, Detlef K., Geissler, Michael, Staib, Ludger, Tannapfel, Andrea, Kleger, Alexander, Beutel, Alica, Schulte, Lucas-Alexander, Kornmann, Marko, Ettrich, Thomas J., Seufferlein, Thomas
Publicado 2019

Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh(®TM)) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer...

por Dorman, Klara, Boeck, Stefan, Snijder, Robert J., Siveke, Jens T., Schenk, Michael, Mayerle, Julia, Caca, Karel, Freiberg-Richter, Jens, Fischer von Weikersthal, Ludwig, Kullmann, Frank, Reinacher-Schick, Anke, Fuchs, Martin, Kanzler, Stephan, Kunzmann, Volker, Ettrich, Thomas J., Zhang, Danmei, Held, Swantje, Abdul-Ahad, Ayad, von Bergwelt-Baildon, Michael, Heinemann, Volker, Haas, Michael
Publicado 2023